Allen Frances shows us how to adjust our therapeutic approach for problems that are simple and those a bit more complex.

We talk with Nick Rosenlicht, MD about what’s gone wrong in the mental health care system.

How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.

How to treat ADHD in bipolar disorder without destabilizing mood part 1: stimulants and non-stimulants.

You’ll never be 100% sure if a patient has bipolar, ADHD, or both, but we’ll get you as close as we can.

How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.

A new med combo for alcohol use disorder, antipsychotic dose reduction in schizophrenia, and two new tips for using stimulants in ADHD.

New studies change how we think about lithium and weight gain, and updates on lumateperone, lavender, and esketamine in depression. 

We count down the top 10 research updates of the past year with a focus on treatment resistant depression and benzo withdrawal.

KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.